TELMISARTAN 40mg. IP + HYDROCHLOROTHIAZIDE 12.5mg. IP + AMLODIPINE 5mg. IP

A single-pill combination of an angiotensin II receptor antagonist, calcium channel antagonist, and diuretic for the treatment of hypertension. Helps to lower high blood pressure that reduces the chances of future heart attacks and strokes. Demonstrates effectiveness in the reduction in systolic BP (SBP) as well as diastolic BP (DBP) in stage II hypertensive patients. (Faruqui, 2008) A suitable treatment option for patients unresponsive to angiotensin II receptor blockers/ calcium channel blockers combinations. (Jitsuo Higaki, 2017) A promising new treatment option for patients with a relatively severe hypertensive condition. (Jitsuo Higaki I. K., 2016) More effective than telmisartan/amlodipine double therapy in reducing BP in patients with hypertension that did not adequately respond to telmisartan/amlodipine. (Ki-Chul Sung, 2018) A beneficial therapeutic choice in the management of patients with hypertension. (M Sharpe, 2001) An attractive choice for difficult-to-control hypertensive patients at cardiovascular risk. (K Ahrens, 2010)